The Patient Safety Commissioner for England’s warning comes as a petition has been launched by pharmacists report growing problems with barcode data errors and missing 2D barcodes on UK medicine packs.
The issue has been highlighted by several ‘Class 4 medicines defect notifications’ during 2025 that were linked to barcode or labelling problems, including fexofenadine hydrochloride tablets in August 2025, and simvastatin tablets in July 2025.
Read full article.
Source: The Pharmaceutical Journal (20 November 2025)
- 0 comments
- 617 views